Fibrin adhesive granulate and method for its preparation
View Patent ↗The invention relates to a flowable fibrin adhesive granulate containing thrombin, Factor XIII, fibrinogen, and a calcium salt in the form of granules with a particle size of more than 50 μm to 1000 μm. Said granulate is useful for the healing of wounds in surgery, tissue therapy and/or as supporting material for biological factors. The invention also relates to an effervescent granulate and an effervescent powder for producing a foam that is suitable for hemostasis. The invention further relates to preparations to arrest bleeding containing a non-woven fabric for wounds consisting of a biodegradable supporting material that is coated with a fibrin glue granulate mixture or mixed granulate.
1. A preparation comprising a fibrin adhesive granulate comprising granulate pellets with a particle size in the range from approximately 50 μm to approximately 1000 μm, wherein the granulate pellets comprise thrombin, Factor XIII, fibrinogen, and a calcium salt; and
wherein the preparation comprises one or more of a wound care fleece, a bandage, a plaster, and a hydrophilic non-aqueous salve base, or wherein the preparation is an effervescent preparation.
2. The preparation according to claim 1 , wherein the preparation is an effervescent preparation further comprising one or more substances required for the formation of CO 2 .
3. The effervescent preparation according to claim 2 , wherein the granulate pellets have a particle size in the range from approximately 100 μm to approximately 200 μm.
4. The effervescent preparation according to claim 2 , wherein the one or more substances required for the formation of CO 2 comprise a mixture of a carbonate and a physiologically safe organic acid.
5. The effervescent preparation according to claim 2 , further comprising one or more substances that promote wound healing.
6. The effervescent preparation according to claim 5 , wherein the one or more substances that promote wound healing are chosen from immunoglobulins, chemotherapeutics, and antibiotics.
7. A tablet comprising an effervescent preparation according to claim 2 .
8. The preparation according to claim 1 , wherein the preparation is a wound care fleece comprising a biodegradable support medium, wherein the biodegradable support medium comprises the fibrin adhesive granulate.
9. The wound care fleece according to claim 8 , wherein the wound care fleece comprises a hydrophilic, non-aqueous salve base, and wherein the salve base comprises the fibrin adhesive granulate.
10. The wound care fleece according to claim 8 , wherein the biodegradable support medium comprises one or more substances chosen from natural and chemically modified collagen, keratin, gelatin, carbohydrates, and cellulose derivatives.
11. The wound care fleece according to claim 8 , wherein the biodegradable support medium comprises one or more polymers chosen from polyhydroxy carboxylic acids, polyesters, polycyano acrylates, polyamino acids, polyalcohols, and silicones.
12. The wound care fleece according to claim 8 , wherein the wound care fleece comprises fibrinogen in the range from approximately 0.05 mg/cm 2 to approximately 50 mg/cm 2 and thrombin in the range from approximately 1 μg/cm 2 to approximately 10 mg/cm 2 .
13. The wound care fleece according to claim 8 , wherein one or both sides of the fleece's support medium contain a composition comprising the fibrin adhesive granulate.
14. The preparation according to claim 1 , wherein the preparation is a bandage comprising a wound care fleece comprising a biodegradable support medium, wherein the biodegradable support medium comprises the fibrin adhesive granulate.
15. The preparation according to claim 1 , wherein the preparation is a plaster comprising a water proof or water permeable material.
16. The preparation according to claim 15 , wherein the plaster comprises adhesive strips.
17. The preparation according to claim 1 , wherein the preparation is a hydrophilic, non-aqueous salve base comprising the fibrin adhesive granulate.
18. The preparation according to claim 17 , wherein the salve base comprises one or more polyols.
19. The preparation according to claim 18 , wherein the one or more polyols are chosen from polyethylene glycols, polypropylene glycols, and ethylene propylene copolymers.
20. The preparation according to claim 1 , wherein the fibrin adhesive granulate is prepared by:
(a) providing solutions or suspensions of the thrombin, and the fibrinogen with factor XIII;
(b) drying the solutions in a fluidized bed apparatus; and
(c) forming the flowable solid granules with a particle size of approximately 50-1000 μm.
21. A method for preparing a preparation according to claim 8 , comprising layering the fibrin adhesive granulate on a biodegradable support medium.
22. A method for preparing a preparation as claimed in claim 17 , comprising mixing the fibrin adhesive granulate with the hydrophilic, non-aqueous salve base.
23. A method for releasing a substance comprising:
adding the substance to a fibrin adhesive granulate comprising granulate pellets with a particle size in the range from approximately 50 μm to approximately 1000 μm, wherein said granulate pellets comprise thrombin, Factor XIII, fibrinogen, and a calcium salt; and
applying a preparation comprising the fibrin adhesive granulate to a desired site, wherein the substance is chosen from biological, vegetable and synthetic factors.
24. The method according to claim 23 , wherein the substance supports wound healing or acts as an antifibrinolytic, antibiotic, chemotherapeutic or immune modulator.